Openness in Nigeria’s public pharmaceutical sector as seen from the eyes of the policy makers

5^th International Conference and Exhibition on Pharmaceutical Regulatory Affairs

August 03-05, 2015 Orlando, USA

Adeyemi Oluwatosin Dotun

Morio Pharmacuetical Nigeria Limited, Nigeria

Posters-Accepted Abstracts: Pharmaceut Reg Affairs

Abstract :

Pharmaceuticals are an important part of health care systems across the world, hence, any weakness in regulations especially in the governance of the pharmaceutical system will impact health outcomes retrogressively most importantly in developing countries. Its a common knowledge that of all countries whose pharmaceutical system has taken a negative hit from corruption and is struggling really hard to put the trafficking, importation and production of fake and substandard drugs under check, Nigeria ranks extremely high. There was a massive organizational restructuring within Nigeria�s foremost regulatory body, National Agency for Food and Drug Administration and Control (NAFDAC) back in 2001. This gave birth to measures to drastically reduce fake drugs and regulate pharmaceuticals better. Even with that restructuring, room for improvement still abounds. What this study sole focused on was to evaluate the assumed level of openness, transparency and of course, the likelihood of corruption vulnerability that still exists in registration, procurement, inspection and distribution, which are the four vital areas of Nigeria�s pharmaceutical sector.

Biography :

Email: adeyemioluwatosindotun@gmail.com